— Know what they know.
Not Investment Advice

INGN NASDAQ

Inogen, Inc.
1W: +6.6% 1M: +31.1% 3M: +10.9% YTD: +7.5% 1Y: -18.7% 3Y: +59.9% 5Y: -82.9%
$7.13
+0.05 (+0.71%)
 
Weekly Expected Move ±8.4%
$6 $7 $7 $8 $8
NASDAQ · Healthcare · Medical - Devices · Tech Score Buy · Power 67 · $189.2M mcap · 23M float · 1.22% daily turnover · Short 41% of daily vol
Credit Risk of going bust: lower than 69% of companies Debt: 7.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.06 (down 99.2%), Inogen, Inc. would be worth roughly what it owes.
Total debt $15.8M against a stock market value of $189.2M.
Distance to default 7.46 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $7.9M (short-term plus half of long-term), stock volatility 44.1%; Altman Z 1.57. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Revenue Segmentation

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$349M +3.9% ▲
5Y CAGR: +2.5%
Gross Profit
$166M +7.2% ▲
5Y CAGR: +3.7%
Operating Income
-$30M +29.0% ▲
Net Income
-$23M +36.6% ▲
EPS (Diluted)
$-0.85 +44.1% ▲
EBITDA
-$3M +87.4% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$358M$377M$316M$336M$349M
YoY Growth+16.1%+5.4%-16.3%+6.4%+3.9%
Cost of Revenue$182M$224M$189M$181M$183M
Gross Profit$176M$154M$127M$155M$166M
Gross Margin49.3%40.7%40.1%46.1%47.6%
R&D Expenses$17M$22M$21M$22M$19M
SG&A Expenses$151M$165M$182M$176M$165M
Operating Expenses$167M$239M$236M$197M$196M
Operating Income$9M-$85M-$109M-$43M-$30M
Operating Margin2.6%-22.6%-34.7%-12.7%-8.7%
Interest Expense$0$0$0$0$0
Income Before Tax$9M-$83M-$102M-$36M-$23M
Tax Expense$15M$504K$105K-$588K-$632K
Net Income-$6M-$84M-$102M-$36M-$23M
Net Margin-1.8%-22.2%-32.5%-10.7%-6.5%
EPS (Diluted)$-0.28$-3.67$-4.42$-1.52$-0.85
EBITDA$31M-$10M-$58M-$22M-$3M
Shares Outstanding22M23M23M24M27M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms